Anatomic Pathology Market

F. Hoffmann-La Roche Ltd. (Switzerland) and Danaher Corporation (US) are leading players in Anatomic Pathology Market

The global anatomic pathology market size is projected to reach USD 46.8 billion by 2025 from USD 33.3 billion in 2020, at a CAGR of 7.1%. Market growth is driven by the high prevalence of cancer and other target diseases, government support for such initiatives, availability of reimbursement, and the growing focus on personalized medicine. In addition, emerging economies such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the anatomic pathology market during the forecast period. However, the availability of refurbished products, the lack of skilled professionals, and product recalls are expected to hamper the market growth to a certain extent in the coming years.

The anatomic pathology market is consolidated in nature. The leading players in this market include F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Hologic, Inc. (US), Agilent Technologies (US), Becton, Dickinson and Company (US), Sakura Finetek (Japan), Bio SB (US), Diapath S.p.A. (Italy), and BioGenex Laboratories (US). The key strategies followed by most companies in this market are product launches and expansions.  

To know about the assumptions considered for the study download the pdf brochure

F. Hoffmann-La Roche Ltd. (Switzerland) is the leading player in the anatomic pathology market. The company offers a full range of consumables that are used for the diagnosis of various types of diseases, including cancers of the lung, breast, and blood. Roche’s strong geographic presence, robust distribution channels, and an impressive brand image enable it to maintain a leading position in the anatomic pathology market. The company focuses on organic growth strategies. For instance, in 2020, the company has launched the CINTEC Plus cytology test. Similarly, in 2018, the company received CE approval for its BenchMark ULTRA Plus Staining System.

Danaher Corporation (US) accounted for the second-largest share of the anatomic pathology market in 2018. The company has a broad product portfolio in the instruments segment and a strong geographic presence across the globe with its direct distribution channels. Over the years, the company has maintained its leading position in the market through continuous innovation and the launch of advanced products. For example, in May 2018, the company launched various clinical microtomes, such as HistoCore BIOCUT, HistoCore MULTICUT, and HistoCoreAUTOCUT clinical microtomes. Similarly, in September 2018, the company launched the HistoCore SPECTRA Workstation.

Related Report

Anatomic Pathology Market by Product & Service [Instruments (Tissue Processors, Microtome), Consumables (Antibodies), Histopathology], Application (Disease Diagnosis (Cancer (Gastrointestinal, Lung)], End User, Region - Global Forecasts to 2025

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Report Code
MD 5104
RI Published ON
7/27/2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Anatomic Pathology Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved